
Patricia L. Morris
Examiner (ID: 11378)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1203, 1201, 1209, 1625 |
| Total Applications | 3798 |
| Issued Applications | 2697 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5771706
[patent_doc_number] => 20050267157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Magnesium-S-omeprazole'
[patent_app_type] => utility
[patent_app_number] => 10/855809
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20483
[patent_no_of_claims] => 101
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267157.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855809 | Magnesium-S-omeprazole | May 27, 2004 | Abandoned |
Array
(
[id] => 7089773
[patent_doc_number] => 20050009886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => '1,4-Dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety'
[patent_app_type] => utility
[patent_app_number] => 10/851293
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 13815
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009886.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851293
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851293 | 1,4-Dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety | May 23, 2004 | Abandoned |
Array
(
[id] => 4705165
[patent_doc_number] => 20080064689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => '3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents'
[patent_app_type] => utility
[patent_app_number] => 11/569148
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34208
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569148
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569148 | 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents | May 23, 2004 | Abandoned |
Array
(
[id] => 7265108
[patent_doc_number] => 20040242644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => '(IS-5S)-3-(5,6-dichloro-3-pyridinyl-)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent'
[patent_app_type] => new
[patent_app_number] => 10/851917
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11324
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851917 | (IS-5S)-3-(5,6-dichloro-3-pyridinyl-)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent | May 20, 2004 | Abandoned |
Array
(
[id] => 7056504
[patent_doc_number] => 20050277679
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2005-12-15
[patent_title] => 'Sodium salts of 5-\'4-\'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione'
[patent_app_type] => utility
[patent_app_number] => 10/849603
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4186
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0277/20050277679.pdf
[firstpage_image] =>[orig_patent_app_number] => 10849603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/849603 | Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione | May 18, 2004 | Abandoned |
Array
(
[id] => 7056504
[patent_doc_number] => 20050277679
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2005-12-15
[patent_title] => 'Sodium salts of 5-\'4-\'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione'
[patent_app_type] => utility
[patent_app_number] => 10/849603
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4186
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0277/20050277679.pdf
[firstpage_image] =>[orig_patent_app_number] => 10849603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/849603 | Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione | May 17, 2004 | Abandoned |
Array
(
[id] => 7449982
[patent_doc_number] => 20040186288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => '3,5-Diamino-1,2,4-triazoles as kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/477126
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5437
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477126
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477126 | 3,5-Diamino-1,2,4-triazoles as kinase inhibitors | May 17, 2004 | Abandoned |
Array
(
[id] => 7061810
[patent_doc_number] => 20050004172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes'
[patent_app_type] => utility
[patent_app_number] => 10/847900
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15461
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847900 | Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes | May 16, 2004 | Abandoned |
Array
(
[id] => 4705353
[patent_doc_number] => 20080064877
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2008-03-13
[patent_title] => 'PROCESS FOR THE PREPARATION OF ROSIGLITAZONE'
[patent_app_type] => utility
[patent_app_number] => 11/579439
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2421
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0064/20080064877.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579439
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579439 | Process for the Preparation of Rosiglitazone | May 11, 2004 | Abandoned |
Array
(
[id] => 7352188
[patent_doc_number] => 20040248945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Thiazolidinedione derivative and its use as antidiabetic'
[patent_app_type] => new
[patent_app_number] => 10/843741
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2963
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843741
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843741 | Thiazolidinedione derivative and its use as antidiabetic | May 11, 2004 | Abandoned |
Array
(
[id] => 4705353
[patent_doc_number] => 20080064877
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2008-03-13
[patent_title] => 'PROCESS FOR THE PREPARATION OF ROSIGLITAZONE'
[patent_app_type] => utility
[patent_app_number] => 11/579439
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2421
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0064/20080064877.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579439
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579439 | Process for the Preparation of Rosiglitazone | May 11, 2004 | Abandoned |
Array
(
[id] => 5662145
[patent_doc_number] => 20060252741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => '3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 10/554665
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26448
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554665 | 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists | May 11, 2004 | Abandoned |
Array
(
[id] => 4628
[patent_doc_number] => 07812016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'Naphthyridine integrase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/556311
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37397
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/812/07812016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556311 | Naphthyridine integrase inhibitors | May 11, 2004 | Issued |
Array
(
[id] => 7127964
[patent_doc_number] => 20050059708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Processes for making thiazolidinedione derivatives and compounds thereof'
[patent_app_type] => utility
[patent_app_number] => 10/842635
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7863
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842635
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842635 | Processes for making thiazolidinedione derivatives and compounds thereof | May 10, 2004 | Abandoned |
Array
(
[id] => 7216933
[patent_doc_number] => 20050054684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same'
[patent_app_type] => utility
[patent_app_number] => 10/842696
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4180
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842696 | Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same | May 10, 2004 | Issued |
Array
(
[id] => 758215
[patent_doc_number] => 07015237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Pyridine matrix metalloproteinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/842863
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12998
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 496
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842863
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842863 | Pyridine matrix metalloproteinase inhibitors | May 9, 2004 | Issued |
Array
(
[id] => 5689039
[patent_doc_number] => 20060287354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Azaindole compounds as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/556227
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10157
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556227
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556227 | Azaindole compounds as kinase inhibitors | May 5, 2004 | Abandoned |
Array
(
[id] => 5057634
[patent_doc_number] => 20070060556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Barium salt of benzimidazole derivative'
[patent_app_type] => utility
[patent_app_number] => 10/555628
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2413
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555628 | Barium salt of benzimidazole derivative | May 2, 2004 | Abandoned |
Array
(
[id] => 5662204
[patent_doc_number] => 20060252800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Anti-leishmania agent'
[patent_app_type] => utility
[patent_app_number] => 10/555539
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7928
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555539
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555539 | Anti-leishmania agent | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7688621
[patent_doc_number] => 20070106077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Synthesis of substituted heterocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/555740
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8331
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20070106077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555740 | Synthesis of substituted heterocyclic compounds | Apr 29, 2004 | Issued |